Amgen - 40 Year Stock Price History | AMGN

Historical daily share price chart and data for Amgen since 1984 adjusted for splits and dividends. The latest closing stock price for Amgen as of April 12, 2024 is 267.28.
  • The all-time high Amgen stock closing price was 322.05 on February 01, 2024.
  • The Amgen 52-week high stock price is 329.72, which is 23.4% above the current share price.
  • The Amgen 52-week low stock price is 211.71, which is 20.8% below the current share price.
  • The average Amgen stock price for the last 52 weeks is 262.40.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Amgen Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2024 288.6030 295.0931 322.0533 266.4500 267.2800 -6.48%
2023 244.0907 250.9133 286.2321 209.2555 285.7955 13.47%
2022 232.9374 210.7391 278.4880 205.6045 251.8626 20.43%
2021 211.6785 204.3866 235.4246 184.8859 209.1401 0.87%
2020 205.8976 210.7052 232.1817 161.0761 207.3262 -2.00%
2019 170.1339 164.6019 213.4257 144.8753 211.5564 26.70%
2018 159.2089 147.5667 178.6261 139.4555 166.9779 15.17%
2017 140.5080 122.2625 158.1735 122.2625 144.9822 22.25%
2016 124.9861 125.1258 141.4853 108.9377 118.5961 -7.55%
2015 123.7522 123.8440 138.1737 103.9567 128.2789 3.97%
2014 100.6831 87.9966 132.9450 84.6091 123.3792 42.32%
2013 78.3498 66.5115 89.8206 61.2368 86.6934 34.80%
2012 56.5099 46.9361 67.2725 46.6798 64.3106 36.80%
2011 40.7152 40.2491 47.3973 34.9743 47.0093 18.18%
2010 40.3949 41.8180 44.2993 36.4886 39.7781 -2.95%
2009 39.7892 42.7416 46.6686 32.6847 40.9881 -2.04%
2008 37.0547 33.7643 47.7410 28.9605 41.8431 24.35%
2007 41.9695 49.5596 54.9576 33.6484 33.6484 -32.02%
2006 51.1855 58.2253 58.2253 46.3136 49.4944 -13.38%
2005 50.6823 46.5745 62.4350 41.4446 57.1385 22.93%
2004 42.6767 45.1761 47.9873 38.1841 46.4803 3.82%
2003 44.5158 35.7351 51.8347 35.4163 44.7703 27.82%
2002 35.7871 40.8650 45.2703 22.5120 35.0250 -14.35%
2001 45.1503 45.5601 53.7548 37.3219 40.8939 -11.73%
2000 47.4378 45.6035 56.5154 37.1770 46.3281 6.46%
1999 26.8878 19.4543 47.0092 18.9761 43.5168 129.89%
1998 12.1047 9.7706 19.0015 8.5371 18.9290 93.05%
1997 10.0952 9.8955 12.3863 8.3324 9.8051 -0.46%
1996 10.5783 10.5512 11.7738 9.3285 9.8502 -8.42%
1995 7.3832 5.2756 10.7559 5.1171 10.7559 101.29%
1994 4.3852 4.4487 5.3779 3.2025 5.3435 19.19%
1993 3.8084 6.3959 6.4077 2.8529 4.4831 -29.91%
1992 5.8408 6.7700 7.0417 4.5284 6.3959 -6.77%
1991 4.0917 1.9246 6.8605 1.7434 6.8605 265.06%
1990 1.1926 0.7774 1.9131 0.6755 1.8793 154.10%
1989 0.6619 0.4830 0.9057 0.4811 0.7396 45.19%
1988 0.4616 0.4868 0.5396 0.3887 0.5094 8.87%
1987 0.4866 0.3567 0.6717 0.2453 0.4679 40.89%
1986 0.3053 0.1905 0.4284 0.1887 0.3321 62.95%
1985 0.1158 0.0717 0.2189 0.0697 0.2038 169.93%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $143.240B $28.190B
Amgen Inc. is the leading biotech companies world wide, with a strong presence in the oncology/hematology, cardiovascular disease, neuroscience, inflammation, bone health & nephrology and neuroscience markets. It developed two most successful drugs, Epogen & Neupogen. Amgen successfully launched two next-generation products, Aranesp & Neulasta and also a biosimilar drug, Prolia/Xgeva. The acquisition of Immunex Corp gave Amgen access to the multi-blockbuster drug, Enbrel. Other products are Repatha, Blincyto, Parsabiv, Evenity, Aimovig, Lumakras/Lumykras, Kanjinti, Mvasi & Amgevita biosimilars. Amgen also has a promising pipeline of cancer drugs. It has one of the strongest cash positions in the biotech sector, which could be used to acquire more pipeline assets that could fuel long-term growth. The erythropoiesis-stimulating agents and granulocyte colony-stimulating factor franchise comprise Epogen/Aranesp and Neupogen/Neulasta respectively. Biosimilar drugs are also a key part of Amgen's growth strategy.
Stock Name Country Market Cap PE Ratio
Vertex Pharmaceuticals (VRTX) United States $102.492B 29.50
Regeneron Pharmaceuticals (REGN) United States $99.302B 24.07
Bristol Myers Squibb (BMY) United States $97.852B 6.44
CSL (CSLLY) Australia $88.445B 0.00
Gilead Sciences (GILD) United States $84.752B 10.13
GSK (GSK) United Kingdom $84.265B 10.56
Moderna (MRNA) United States $40.256B 0.00
Biogen (BIIB) United States $28.808B 13.45
Argenex SE (ARGX) Netherlands $22.417B 0.00
BioNTech SE (BNTX) Germany $20.559B 20.99
Illumina (ILMN) United States $20.237B 146.06
Genmab (GMAB) Denmark $19.348B 24.80
Alnylam Pharmaceuticals (ALNY) United States $18.703B 0.00
BioMarin Pharmaceutical (BMRN) United States $17.405B 73.78
BeiGene (BGNE) Cayman Islands $13.514B 0.00
Exact Sciences (EXAS) United States $12.950B 0.00
Incyte (INCY) United States $12.091B 20.09
Sarepta Therapeutics (SRPT) United States $11.537B 0.00
Bio-Techne Corp (TECH) United States $10.489B 39.02
Bio-Rad Laboratories (BIO.B) United States $9.655B 28.76
Legend Biotech (LEGN) United States $9.627B 0.00
Repligen (RGEN) United States $9.578B 99.15
QIAGEN (QGEN) Netherlands $9.169B 18.98
Roivant Sciences (ROIV) United Kingdom $8.816B 0.00
Ascendis Pharma (ASND) Denmark $8.503B 0.00
Viking Therapeutics (VKTX) United States $7.563B 0.00
Cytokinetics (CYTK) United States $7.483B 0.00
Exelixis (EXEL) United States $6.916B 35.64
Vaxcyte (PCVX) United States $6.708B 0.00
Intra-Cellular Therapies (ITCI) United States $6.378B 0.00
Apellis Pharmaceuticals (APLS) United States $6.245B 0.00
Blueprint Medicines (BPMC) United States $5.340B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $5.150B 0.00
Krystal Biotech (KRYS) United States $4.951B 0.00
Halozyme Therapeutics (HALO) United States $4.906B 15.14
Biohaven (BHVN) United States $4.331B 0.00
Zealand Pharma (ZLDPF) Denmark $4.276B 0.00
Immunovant (IMVT) United States $4.264B 0.00
Nuvalent (NUVL) United States $4.197B 0.00
Alkermes (ALKS) Ireland $4.131B 21.80
Insmed (INSM) United States $4.048B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.868B 0.00
Fortrea Holdings (FTRE) United States $3.490B 0.00
ImmunityBio (IBRX) United States $3.459B 0.00
Iovance Biotherapeutics (IOVA) United States $3.452B 0.00
Axsome Therapeutics (AXSM) United States $3.276B 0.00
Apogee Therapeutics (APGE) United States $3.217B 0.00
Amicus Therapeutics (FOLD) United States $3.155B 0.00
SpringWorks Therapeutics (SWTX) United States $3.154B 0.00
IDEAYA Biosciences (IDYA) United States $3.129B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.116B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.115B 0.00
Arcellx (ACLX) United States $3.095B 0.00
Certara (CERT) United States $2.831B 60.93
ACADIA Pharmaceuticals (ACAD) United States $2.824B 0.00
Immunocore Holdings (IMCR) United Kingdom $2.816B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $2.805B 0.00
MorphoSys AG (MOR) Germany $2.720B 0.00
Janux Therapeutics (JANX) United States $2.720B 0.00
CG Oncology (CGON) United States $2.649B 0.00
Vera Therapeutics (VERA) United States $2.612B 0.00
Denali Therapeutics (DNLI) United States $2.541B 0.00
Arvinas (ARVN) United States $2.471B 0.00
Merus (MRUS) Netherlands $2.456B 0.00
Rhythm Pharmaceuticals (RYTM) United States $2.425B 0.00
Intellia Therapeutics (NTLA) United States $2.333B 0.00
Vericel (VCEL) United States $2.317B 0.00
Guardant Health (GH) United States $2.222B 0.00
Celldex Therapeutics (CLDX) United States $2.194B 0.00
Rocket Pharmaceuticals (RCKT) United States $2.189B 0.00
Kymera Therapeutics (KYMR) United States $2.174B 0.00
Ginkgo Bioworks Holdings (DNA) United States $2.174B 0.00
Neumora Therapeutics (NMRA) United States $2.155B 0.00
Beam Therapeutics (BEAM) United States $2.117B 0.00
Keros Therapeutics (KROS) United States $2.109B 0.00
Galapagos (GLPG) Belgium $1.993B 0.00
Geron (GERN) United States $1.991B 0.00
Sana Biotechnology (SANA) United States $1.975B 0.00
Avidity Biosciences (RNA) United States $1.920B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.845B 0.00
Structure Therapeutics (GPCR) United States $1.832B 0.00
NeoGenomics (NEO) United States $1.799B 0.00
Twist Bioscience (TWST) United States $1.774B 0.00
Myriad Genetics (MYGN) United States $1.757B 0.00
Bavarian Nordic (BVNRY) Denmark $1.703B 5.59
Harmony Biosciences Holdings (HRMY) United States $1.675B 13.91
Inhibrx (INBX) United States $1.658B 0.00
Protagonist Therapeutics (PTGX) United States $1.576B 0.00
Dynavax Technologies (DVAX) United States $1.549B 0.00
Edgewise Therapeutics (EWTX) United States $1.524B 0.00
Arcus Biosciences (RCUS) United States $1.507B 0.00
Kura Oncology (KURA) United States $1.483B 0.00
Ligand Pharmaceuticals (LGND) United States $1.441B 17.84
Gyre Therapeutics (GYRE) United States $1.436B 0.00
Morphic Holding (MORF) United States $1.434B 0.00
Zai Lab (ZLAB) China $1.420B 0.00
ANI Pharmaceuticals (ANIP) United States $1.410B 17.33
ADMA Biologics Inc (ADMA) United States $1.374B 0.00
Autolus Therapeutics (AUTL) United Kingdom $1.335B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $1.286B 0.00
AbCellera Biologics (ABCL) Canada $1.271B 0.00
Akero Therapeutics (AKRO) United States $1.249B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.238B 0.00
Immunome (IMNM) United States $1.229B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.221B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.216B 0.00
Vir Biotechnology (VIR) United States $1.206B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.203B 0.00
Prothena (PRTA) Ireland $1.195B 0.00
Mirum Pharmaceuticals (MIRM) United States $1.155B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.153B 0.00
MannKind (MNKD) United States $1.123B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $1.119B 0.00
Belite Bio (BLTE) United States $1.076B 0.00
Liquidia Technologies (LQDA) United States $1.061B 0.00
Scholar Rock Holding (SRRK) United States $1.047B 0.00
Viridian Therapeutics (VRDN) United States $0.997B 0.00
Arcutis Biotherapeutics (ARQT) United States $0.988B 0.00
Kyverna Therapeutics (KYTX) United States $0.982B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.952B 0.00
MiMedx (MDXG) United States $0.946B 214.67
Abivax SA (ABVX) France $0.944B 0.00
89BIO (ETNB) United States $0.918B 0.00
Immatics (IMTX) Germany $0.898B 0.00
REGENXBIO (RGNX) United States $0.887B 0.00
Pliant Therapeutics (PLRX) United States $0.852B 0.00
Nurix Therapeutics (NRIX) United States $0.823B 0.00
Cabaletta Bio (CABA) United States $0.822B 0.00
CARGO Therapeutics (CRGX) United States $0.820B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.819B 0.00
Cytek Biosciences (CTKB) United States $0.807B 0.00
Tango Therapeutics (TNGX) United States $0.785B 0.00
Tyra Biosciences (TYRA) United States $0.782B 0.00
Disc Medicine (IRON) United States $0.768B 0.00
Dianthus Therapeutics (DNTH) United States $0.760B 0.00
HilleVax (HLVX) United States $0.747B 0.00
Praxis Precision Medicines (PRAX) United States $0.730B 0.00
PureTech Health (PRTC) United States $0.730B 0.00
Cullinan Oncology (CGEM) United States $0.718B 0.00
WAVE Life Sciences (WVE) Singapore $0.709B 0.00
Pharming Group (PHAR) Netherlands $0.707B 0.00
Aerovate Therapeutics (AVTE) United States $0.703B 0.00
Pharming Group (PHGUF) Netherlands $0.695B 0.00
Longboard Pharmaceuticals (LBPH) United States $0.692B 0.00
Prime Medicine (PRME) United States $0.687B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.679B 0.00
EnGene Holdings (ENGN) United States $0.671B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.670B 0.00
Oric Pharmaceuticals (ORIC) United States $0.660B 0.00
Absci (ABSI) United States $0.658B 0.00
ALX Oncology Holdings (ALXO) United States $0.653B 0.00
Zymeworks (ZYME) United States $0.653B 0.00
CureVac (CVAC) Germany $0.651B 0.00
Nuvation Bio (NUVB) United States $0.648B 0.00
Mineralys Therapeutics (MLYS) United States $0.646B 0.00
Allogene Therapeutics (ALLO) United States $0.643B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.629B 0.00
Northwest Biotherapeutics (NWBO) United States $0.625B 0.00
Cogent Biosciences (COGT) United States $0.622B 0.00
Mesoblast (MESO) Australia $0.613B 0.00
AnaptysBio (ANAB) United States $0.608B 0.00
Olema Pharmaceuticals (OLMA) United States $0.607B 0.00
Novavax (NVAX) United States $0.599B 0.00
Astria Therapeutics (ATXS) United States $0.594B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.593B 0.00
Stoke Therapeutics (STOK) United States $0.591B 0.00
GH Research (GHRS) Ireland $0.582B 0.00
Alector (ALEC) United States $0.576B 0.00
Fate Therapeutics (FATE) United States $0.573B 0.00
ArriVent BioPharma (AVBP) United States $0.566B 0.00
Celcuity (CELC) United States $0.558B 0.00
Castle Biosciences (CSTL) United States $0.551B 0.00
Applied Therapeutics (APLT) United States $0.546B 0.00
IGM Biosciences (IGMS) United States $0.538B 0.00
Annexon (ANNX) United States $0.538B 0.00
ACELYRIN, INC (SLRN) United States $0.528B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.527B 0.00
Arbutus Biopharma (ABUS) United States $0.522B 0.00
Neurogene (NGNE) United States $0.510B 0.00
C4 Therapeutics (CCCC) United States $0.508B 0.00
Editas Medicine (EDIT) United States $0.508B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.485B 0.00
Travere Therapeutics (TVTX) United States $0.485B 0.00
Oculis Holding AG (OCS) Switzerland $0.484B 0.00
Third Harmonic Bio (THRD) United States $0.469B 0.00
Biomea Fusion (BMEA) United States $0.466B 0.00
Fulcrum Therapeutics (FULC) United States $0.465B 0.00
Mersana Therapeutics (MRSN) United States $0.462B 0.00
Voyager Therapeutics (VYGR) United States $0.458B 2.73
Shattuck Labs (STTK) United States $0.443B 0.00
Ocugen (OCGN) United States $0.439B 0.00
Replimune (REPL) United States $0.438B 0.00
Adaptive Biotechnologies (ADPT) United States $0.437B 0.00
Entrada Therapeutics (TRDA) United States $0.435B 0.00
Nkarta (NKTX) United States $0.432B 0.00
Revance Therapeutics (RVNC) United States $0.430B 0.00
Avid Bioservices (CDMO) United States $0.426B 0.00
PepGen (PEPG) United States $0.421B 0.00
ITeos Therapeutics (ITOS) United States $0.420B 0.00
MaxCyte (MXCT) United States $0.418B 0.00
Jasper Therapeutics (JSPR) United States $0.418B 0.00
Amarin (AMRN) Ireland $0.393B 0.00
Solid Biosciences (SLDB) United States $0.392B 0.00
Adlai Nortye (ANL) Cayman Islands $0.390B 0.00
Alto Neuroscience (ANRO) United States $0.384B 0.00
Caribou Biosciences (CRBU) United States $0.379B 0.00
Aura Biosciences (AURA) United States $0.373B 0.00
Anika Therapeutics (ANIK) United States $0.371B 0.00
TScan Therapeutics (TCRX) United States $0.371B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.362B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.362B 0.00
MeiraGTx Holdings (MGTX) United States $0.357B 0.00
Urogen Pharma (URGN) United States $0.354B 0.00
Precigen (PGEN) United States $0.353B 0.00
Anavex Life Sciences (AVXL) United States $0.353B 0.00
Invivyd (IVVD) United States $0.352B 0.00
Tenaya Therapeutics (TNYA) United States $0.350B 0.00
FibroBiologics (FBLG) United States $0.349B 0.00
Humacyte (HUMA) United States $0.343B 0.00
MEREO BIOPHARMA (MREO) United Kingdom $0.340B 0.00
Terns Pharmaceuticals (TERN) United States $0.332B 0.00
Ventyx Biosciences (VTYX) United States $0.324B 0.00
CorMedix Inc (CRMD) United States $0.320B 0.00
Rapt Therapeutics (RAPT) United States $0.320B 0.00
Erasca (ERAS) United States $0.320B 0.00
Inozyme Pharma (INZY) United States $0.318B 0.00
Atea Pharmaceuticals (AVIR) United States $0.316B 0.00
Nautilus Biotechnology (NAUT) United States $0.309B 0.00
XOMA (XOMA) United States $0.301B 0.00
Kamada (KMDA) Israel $0.295B 22.35
ChromaDex (CDXC) United States $0.290B 0.00
Verastem (VSTM) United States $0.286B 0.00
Contineum Therapeutics (CTNM) $0.283B 0.00
XBiotech (XBIT) United States $0.282B 0.00
AC Immune (ACIU) Switzerland $0.271B 0.00
Rani Therapeutics Holdings (RANI) United States $0.271B 0.00
Poseida Therapeutics (PSTX) United States $0.263B 0.00
2seventy Bio (TSVT) United States $0.259B 0.00
Sutro Biopharma (STRO) United States $0.259B 0.00
Inovio Pharmaceuticals (INO) United States $0.258B 0.00
Puma Biotechnology (PBYI) United States $0.254B 11.46
Oxford BioMedica (OXBDF) United Kingdom $0.252B 0.00
Coherus BioSciences (CHRS) United States $0.251B 0.00
Cardiff Oncology (CRDF) United States $0.251B 0.00
Adverum Biotechnologies (ADVM) United States $0.243B 0.00
G1 Therapeutics (GTHX) United States $0.238B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.237B 82.40
Kodiak Sciences (KOD) United States $0.232B 0.00
Elevation Oncology (ELEV) United States $0.230B 0.00
UniQure (QURE) Netherlands $0.229B 0.00
Ovid Therapeutics (OVID) United States $0.226B 0.00
X4 Pharmaceuticals (XFOR) United States $0.225B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.225B 0.00
Compass Therapeutics (CMPX) United States $0.223B 0.00
Opthea (OPT) Australia $0.222B 0.00
Scilex Holding (SCLX) United States $0.221B 0.00
Prima BioMed (IMMP) Australia $0.219B 0.00
23andMe Holding (ME) United States $0.214B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.213B 0.00
Design Therapeutics (DSGN) United States $0.208B 0.00
BioStem Technologies (BSEM) $0.207B 0.00
Abeona Therapeutics (ABEO) United States $0.207B 0.00
Akoya Biosciences (AKYA) United States $0.203B 0.00
Gossamer Bio (GOSS) United States $0.202B 0.00
Codexis (CDXS) United States $0.202B 0.00
Trevi Therapeutics (TRVI) United States $0.201B 0.00
Greenwich LifeSciences (GLSI) United States $0.201B 0.00
Innate Pharma S.A (IPHA) France $0.201B 0.00
Werewolf Therapeutics (HOWL) United States $0.200B 0.00
Candel Therapeutics (CADL) United States $0.195B 0.00
INmune Bio (INMB) United States $0.187B 0.00
Inventiva S.A (IVA) France $0.186B 0.00
Compugen (CGEN) Israel $0.185B 0.00
Alimera Sciences (ALIM) United States $0.184B 0.00
Lifecore Biomedical (LFCR) United States $0.184B 0.00
LENZ Therapeutics (LENZ) United States $0.182B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.179B 0.00
GENFIT S.A (GNFT) France $0.178B 0.00
ScPharmaceuticals (SCPH) United States $0.178B 0.00
Adicet Bio (ACET) United States $0.177B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.175B 0.00
Agenus (AGEN) United States $0.171B 0.00
Skye Bioscience (SKYE) United States $0.159B 0.00
Renovaro (RENB) United States $0.157B 0.00
CervoMed (CRVO) United States $0.155B 0.00
Sagimet Biosciences (SGMT) United States $0.154B 0.00
Spyre Therapeutics (SYRE) United States $0.152B 0.00
BioAtla (BCAB) United States $0.151B 0.00
Cellectis S.A (CLLS) France $0.150B 0.00
Omega Therapeutics (OMGA) United States $0.148B 0.00
I-Mab (IMAB) China $0.146B 0.00
CytomX Therapeutics (CTMX) United States $0.146B 0.00
Zura Bio (ZURA) United States $0.145B 0.00
Molecular Partners AG (MOLN) Switzerland $0.144B 0.00
Syros Pharmaceuticals (SYRS) United States $0.143B 0.00
Repare Therapeutics (RPTX) Canada $0.135B 0.00
DBV Technologies S.A (DBVT) France $0.134B 0.00
VistaGen Therapeutics (VTGN) United States $0.132B 0.00
Coya Therapeutics (COYA) United States $0.132B 0.00
Vor Biopharma (VOR) $0.130B 0.00
Immunic (IMUX) United States $0.130B 0.00
Annovis Bio (ANVS) United States $0.128B 0.00
Nuvectis Pharma (NVCT) United States $0.125B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.122B 0.00
TELA Bio (TELA) United States $0.121B 0.00
Bluebird Bio (BLUE) United States $0.120B 0.00
Seer (SEER) United States $0.119B 0.00
Vigil Neuroscience (VIGL) United States $0.119B 0.00
ATyr Pharma (LIFE) United States $0.118B 0.00
PDS Biotechnology (PDSB) United States $0.117B 0.00
Adagene (ADAG) China $0.117B 0.00
Oncobiologics (OTLK) United States $0.113B 0.00
Genelux (GNLX) United States $0.111B 0.00
Emergent Biosolutions (EBS) United States $0.108B 0.00
Rezolute (RZLT) United States $0.107B 0.00
BioHarvest Sciences (CNVCF) Canada $0.107B 0.00
Cartesian Therapeutics (RNAC) United States $0.105B 0.00
IO Biotech (IOBT) Denmark $0.102B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.101B 0.00
Elicio Therapeutics (ELTX) United States $0.101B 0.00
Seres Therapeutics (MCRB) United States $0.099B 0.00
Alpha Teknova (TKNO) United States $0.098B 0.00
Precision BioSciences (DTIL) United States $0.098B 0.00
Allakos (ALLK) United States $0.098B 0.00
Sangamo Therapeutics (SGMO) United States $0.097B 0.00
Connect Biopharma Holdings (CNTB) United States $0.095B 0.00
Athira Pharma (ATHA) United States $0.094B 0.00
Clearside Biomedical (CLSD) United States $0.093B 0.00
Q32 Bio (QTTB) United States $0.093B 0.00
DiaMedica Therapeutics (DMAC) United States $0.092B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.092B 0.00
Curis (CRIS) United States $0.090B 0.00
BioXcel Therapeutics (BTAI) United States $0.089B 0.00
Spero Therapeutics (SPRO) United States $0.088B 3.28
InflaRx (IFRX) Germany $0.088B 0.00
Eton Pharmaceuticals (ETON) United States $0.088B 0.00
Affimed (AFMD) Germany $0.088B 0.00
Oncolytics Biotech (ONCY) Canada $0.086B 0.00
Entera Bio (ENTX) Israel $0.086B 0.00
Cue Biopharma (CUE) United States $0.085B 0.00
Atara Biotherapeutics (ATRA) United States $0.085B 0.00
Rallybio (RLYB) United States $0.083B 0.00
Leap Therapeutics (LPTX) United States $0.083B 0.00
Passage Bio (PASG) United States $0.083B 0.00
Gritstone Bio (GRTS) United States $0.082B 0.00
AN2 Therapeutics (ANTX) United States $0.082B 0.00
BeyondSpring (BYSI) United States $0.081B 0.00
YS Biopharma (YS) China $0.080B 0.00
Celularity (CELU) United States $0.080B 0.00
HOOKIPA Pharma (HOOK) United States $0.078B 0.00
MediciNova (MNOV) United States $0.077B 0.00
Cognition Therapeutics (CGTX) United States $0.076B 0.00
Ocean Biomedical (OCEA) United States $0.076B 0.00
Aligos Therapeutics (ALGS) United States $0.076B 0.00
Galena Biopharma (SLS) United States $0.075B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.075B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.074B 0.00
Eupraxia Pharmaceuticals (EPRX) $0.074B 0.00
VTv Therapeutics (VTVT) United States $0.074B 0.00
Turnstone Biologics (TSBX) United States $0.074B 0.00
Cidara Therapeutics (CDTX) United States $0.073B 0.00
Immix Biopharma (IMMX) United States $0.073B 0.00
Elutia (ELUT) United States $0.073B 0.00
Instil Bio (TIL) United States $0.071B 0.00
Provectus Biopharmaceuticals (PVCT) United States $0.070B 0.00
Lantern Pharma (LTRN) United States $0.069B 0.00
Kronos Bio (KRON) United States $0.068B 0.00
Landos Biopharma (LABP) United States $0.067B 0.00
Equillium (EQ) United States $0.065B 0.00
Ikena Oncology (IKNA) United States $0.064B 0.00
HCW Biologics (HCWB) United States $0.064B 0.00
Checkpoint Therapeutics (CKPT) United States $0.064B 0.00
Genenta Science S.p.A (GNTA) Italy $0.063B 0.00
Intensity Therapeutics (INTS) United States $0.063B 0.00
Kezar Life Sciences (KZR) United States $0.063B 0.00
Vaxxinity (VAXX) United States $0.062B 0.00
Immuneering (IMRX) United States $0.061B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.060B 0.00
Enzo Biochem (ENZ) United States $0.060B 0.00
AVROBIO (AVRO) United States $0.057B 0.00
NextCure (NXTC) United States $0.054B 0.00
Bionano Genomics (BNGO) United States $0.053B 0.00
Beyond Air (XAIR) United States $0.052B 0.00
Dyadic (DYAI) United States $0.051B 0.00
Apollomics (APLM) United States $0.050B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.050B 0.00
Carmell (CTCX) United States $0.049B 0.00
Aadi Bioscience (AADI) United States $0.048B 0.00
CalciMedica (CALC) United States $0.048B 0.00
Dare Bioscience (DARE) United States $0.047B 0.00
ARCA Biopharma (ABIO) United States $0.047B 0.00
Clene (CLNN) United States $0.046B 0.00
Bolt Biotherapeutics (BOLT) United States $0.046B 0.00
Ocuphire Pharma (OCUP) United States $0.046B 0.00
Promis Neurosciences (PMN) Canada $0.044B 0.00
SAB Biotherapeutics (SABS) United States $0.043B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.042B 0.00
Cara Therapeutics (CARA) United States $0.042B 0.00
Estrella Immunopharma (ESLA) United States $0.041B 0.00
Quince Therapeutics (QNCX) United States $0.041B 0.00
Xilio Therapeutics (XLO) United States $0.041B 0.00
OKYO Pharma (OKYO) $0.040B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.040B 0.00
BRIACELL THERAP (BCTX) Canada $0.040B 0.00
Semper Paratus Acquisition (TVGN) United States $0.039B 0.00
Cyclo Therapeutics (CYTH) United States $0.036B 0.00
IN8bio (INAB) United States $0.036B 0.00
Fortress Biotech (FBIO) United States $0.035B 0.00
Theratechnologies (THTX) Canada $0.034B 0.00
MiNK Therapeutics (INKT) United States $0.034B 0.00
Prenetics Global (PRE) Cayman Islands $0.034B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.034B 0.00
Aprea Therapeutics (APRE) United States $0.031B 0.00
Evogene (EVGN) Israel $0.031B 0.00
Spruce Biosciences (SPRB) United States $0.030B 0.00
Aileron Therapeutics (ALRN) United States $0.030B 0.00
Pluri (PLUR) Israel $0.030B 0.00
Femasys (FEMY) United States $0.029B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.028B 0.00
Lexaria Bioscience (LEXX) Canada $0.027B 0.00
BioAffinity Technologies (BIAF) United States $0.027B 0.00
Sensei Biotherapeutics (SNSE) United States $0.026B 0.00
Forte Biosciences (FBRX) United States $0.026B 0.00
NKGen Biotech (NKGN) United States $0.026B 0.00
UNITY Biotechnology (UBX) United States $0.026B 0.00
Eyenovia (EYEN) United States $0.025B 0.00
Lisata Therapeutics (LSTA) United States $0.024B 0.00
Biora Therapeutics (BIOR) United States $0.024B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.024B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.023B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.022B 0.00
Lumos Pharma (LUMO) United States $0.021B 0.00
Aptose Biosciences (APTO) Canada $0.021B 0.00
Evaxion Biotech (EVAX) Denmark $0.021B 0.00
Vincerx Pharma (VINC) United States $0.021B 0.00
Synlogic (SYBX) United States $0.021B 0.00
RenovoRx (RNXT) United States $0.021B 0.00
KALA BIO (KALA) United States $0.020B 0.00
Galecto (GLTO) Denmark $0.018B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.018B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.017B 0.00
Aytu BioPharma (AYTU) United States $0.016B 0.00
Orgenesis (ORGS) United States $0.016B 0.00
Purple Biotech (PPBT) Israel $0.016B 0.00
Senti Biosciences (SNTI) United States $0.015B 0.00
Talis Biomedical (TLIS) United States $0.015B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.015B 0.00
IMMURON (IMRN) Australia $0.015B 0.00
Imunon (IMNN) United States $0.015B 0.00
Cocrystal Pharma (COCP) United States $0.015B 0.00
Edesa Biotech (EDSA) Canada $0.014B 0.00
Benitec Biopharma (BNTC) United States $0.014B 0.00
VBI Vaccines (VBIV) United States $0.014B 0.00
Prana Biotechnology (ATHE) Australia $0.014B 0.00
Monopar Therapeutics (MNPR) United States $0.014B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.013B 0.00
Genetic Technologies (GENE) Australia $0.013B 0.00
Telesis Bio (TBIO) United States $0.012B 0.00
Eterna Therapeutics (ERNA) United States $0.012B 0.00
NuCana (NCNA) United Kingdom $0.012B 0.00
ABVC BioPharma (ABVC) United States $0.012B 0.00
Biofrontera (BFRI) United States $0.011B 0.00
BioCardia (BCDA) United States $0.010B 0.00
Elevai Labs (ELAB) United States $0.010B 0.00
Moleculin Biotech (MBRX) United States $0.010B 0.00
Organovo Holdings (ONVO) United States $0.010B 0.00
Virios Therapeutics (VIRI) United States $0.010B 0.00
TFF Pharmaceuticals (TFFP) United States $0.010B 0.00
AEterna Zentaris (AEZS) Canada $0.010B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.010B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.010B 0.00
Adial Pharmaceuticals (ADIL) United States $0.009B 0.00
Cyclerion Therapeutics (CYCN) United States $0.009B 0.00
Biorestorative Therapies (BRTX) United States $0.009B 0.00
Galera Therapeutics (GRTX) United States $0.009B 0.00
Chemomab Therapeutics (CMMB) Israel $0.009B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.008B 0.00
Bionomics (BNOX) Australia $0.008B 0.00
Portage Biotech (PRTG) $0.008B 0.00
Sunshine Biopharma (SBFM) United States $0.008B 0.00
Pulmatrix (PULM) United States $0.008B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.008B 0.00
Pasithea Therapeutics (KTTA) United States $0.008B 0.00
EFFECTOR Therapeutics (EFTR) United States $0.008B 0.00
Vaccinex (VCNX) United States $0.008B 0.00
Enveric Biosciences (ENVB) United States $0.007B 0.00
Tenax Therapeutics (TENX) United States $0.007B 0.00
AquaBounty Technologies (AQB) United States $0.007B 0.00
Psyence Biomedical (PBM) United States $0.007B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.007B 0.00
Trevena (TRVN) United States $0.007B 0.00
First Wave BioPharma (FWBI) United States $0.007B 0.00
Titan Pharmaceuticals (TTNP) United States $0.007B 0.00
Cadrenal Therapeutics (CVKD) United States $0.007B 0.00
Atrinsic (PTIX) United States $0.006B 0.00
Seelos Therapeutics (SEEL) United States $0.006B 0.00
PaxMedica (PXMD) United States $0.006B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.006B 0.00
Hoth Therapeutics (HOTH) United States $0.006B 0.00
Alzamend Neuro (ALZN) United States $0.006B 0.00
Novogen (KZIA) Australia $0.006B 0.00
Bright Minds Biosciences (DRUG) United States $0.006B 0.00
Silo Pharma (SILO) United States $0.006B 0.00
Ensysce Biosciences (ENSC) United States $0.005B 0.00
GT Biopharma (GTBP) United States $0.005B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.005B 0.00
TRACON Pharmaceuticals (TCON) United States $0.005B 0.00
Mustang Bio (MBIO) United States $0.005B 0.00
GENPREX (GNPX) United States $0.005B 0.00
Synaptogenix (SNPX) United States $0.005B 0.00
Exicure (XCUR) United States $0.005B 0.35
Artelo Biosciences (ARTL) United States $0.005B 0.00
Kintara Therapeutics (KTRA) United States $0.005B 0.00
Biophytis SA (BPTS) France $0.005B 0.00
Cingulate (CING) United States $0.005B 0.00
Tharimmune (THAR) United States $0.005B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.004B 0.00
Longeveron (LGVN) United States $0.004B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.004B 0.00
Soligenix (SNGX) United States $0.004B 0.00
Kineta (KA) United States $0.004B 0.00
NexImmune (NEXI) United States $0.004B 0.00
GeoVax Labs (GOVX) United States $0.004B 0.00
Avalon GloboCare (ALBT) United States $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.00
Revelation Biosciences (REVB) United States $0.003B 0.00
Onconetix (ONCO) United States $0.003B 0.00
Dermata Therapeutics (DRMA) United States $0.003B 0.00
CNS Pharmaceuticals (CNSP) United States $0.003B 0.00
Notable Labs (NTBL) United States $0.003B 0.00
ThermoGenesis Holdings (THMO) United States $0.003B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.002B 0.00
Windtree Therapeutics (WINT) United States $0.002B 0.00
Invo BioScience (INVO) United States $0.002B 0.00
180 Life Sciences (ATNF) United States $0.002B 0.00
NeuBase Therapeutics (NBSE) United States $0.002B 0.00
GRI Bio (GRI) United States $0.002B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.001B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.001B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.001B 0.00
Bone Biologics (BBLG) United States $0.001B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.001B 0.00
Allarity Therapeutics (ALLR) United States $0.001B 0.00
Aptevo Therapeutics (APVO) United States $0.000B 0.00
Sinovac Biotech (SVA) China $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00